Company Profile

Xactagen LLC
Profile last edited on: 1/21/13      CAGE: 4CXD4      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

16101 Greenwood Avenue North Building 2900
Shoreline, WA 98133
   (206) 533-6779
Location: Single
Congr. District: 07
County: King

Public Profile

Xactagen focuses its genetic engineering expertise on combining highly successful, physiology-based drug discovery with disease-relevant gene and protein data derived from genomics and proteomics. The resulting gene-specific, cell-based assays promise more productive and predictive drug discovery and development, allowing our company to play a significant role in bringing important new medicines to market

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2012 1 NIH $223,352
Project Title: Innovative Approach For High-Volume Production Of Endogenous Reporter Cells
2007 1 NIH $100,000
Project Title: HTS of Microglia for Clearance of Amyloid-Beta in Alzheimer's Disease

Key People / Management

  Robert E Finney -- President

  Josef Peter Klein

Company News

There are no news available.